These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21132558)

  • 41. Comparing the performance of the SF-6D and the EQ-5D in different patient groups.
    Ferreira LN; Ferreira PL; Pereira LN
    Acta Med Port; 2014; 27(2):236-45. PubMed ID: 24813493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease.
    van Stel HF; Buskens E
    Health Qual Life Outcomes; 2006 Mar; 4():20. PubMed ID: 16563170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
    Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
    Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.
    Harrison MJ; Lunt M; Verstappen SM; Watson KD; Bansback NJ; Symmons DP
    Health Qual Life Outcomes; 2010 Feb; 8():21. PubMed ID: 20149253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH; Lang BHH; Yu HMS; Lam CLK
    Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EQ-5D versus SF-12 in coronary patients: are they interchangeable?
    De Smedt D; Clays E; Annemans L; De Bacquer D
    Value Health; 2014; 17(1):84-9. PubMed ID: 24438721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer.
    Yousefi M; Najafi S; Ghaffari S; Mahboub-Ahari A; Ghaderi H
    Iran Red Crescent Med J; 2016 May; 18(5):e23556. PubMed ID: 27437122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Impact of Diabetes-Related Complications on Preference-Based Measures of Health-Related Quality of Life in Adults with Type I Diabetes.
    Peasgood T; Brennan A; Mansell P; Elliott J; Basarir H; Kruger J
    Med Decis Making; 2016 Nov; 36(8):1020-33. PubMed ID: 27553209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes.
    Fenwick EK; Xie J; Ratcliffe J; Pesudovs K; Finger RP; Wong TY; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):677-84. PubMed ID: 22205611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluating a falls prevention intervention in older home care recipients: a comparison of SF-6D and EQ-5D.
    Bjerk M; Brovold T; Davis JC; Bergland A
    Qual Life Res; 2019 Dec; 28(12):3187-3195. PubMed ID: 31364036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China.
    Zhao L; Liu X; Liu D; He Y; Liu Z; Li N
    Medicine (Baltimore); 2019 Mar; 98(11):e14719. PubMed ID: 30882636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients.
    Ameri H; Yousefi M; Yaseri M; Nahvijou A; Arab M; Akbari Sari A
    Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):89-96. PubMed ID: 30173585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes.
    Sayah FA; Qiu W; Xie F; Johnson JA
    Qual Life Res; 2017 Aug; 26(8):2057-2066. PubMed ID: 28364183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.
    Shiroiwa T; Fukuda T; Ikeda S; Igarashi A; Noto S; Saito S; Shimozuma K
    Qual Life Res; 2016 Mar; 25(3):707-19. PubMed ID: 26303761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis.
    Adams R; Walsh C; Veale D; Bresnihan B; FitzGerald O; Barry M
    Pharmacoeconomics; 2010; 28(6):477-87. PubMed ID: 20465316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of three health-related quality of life instruments in relation to visual acuity: EQ-5D, 15D, and EUROHIS-QOL8.
    Purola PKM; Koskinen SVP; Uusitalo HMT
    Qual Life Res; 2023 Feb; 32(2):543-552. PubMed ID: 36385360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia.
    Xu RH; Dong D; Luo N; Wong EL; Wu Y; Yu S; Yang R; Liu J; Yuan H; Zhang S
    Eur J Health Econ; 2021 Jun; 22(4):547-557. PubMed ID: 33761029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population.
    Jalkanen K; Aarnio E; Lavikainen P; Jauhonen HM; Enlund H; Martikainen J
    Health Qual Life Outcomes; 2019 Jul; 17(1):117. PubMed ID: 31286982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.